
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Astrazeneca Plc | AZN | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
10,188.00 | 10,138.00 | 10,304.00 | 10,126.00 |
Industry Sector |
---|
PHARMACEUTICALS & BIOTECHNOLOGY |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
09/02/2023 | Interim | GBP | 0.718 | 10/08/2023 | 11/08/2023 | 11/09/2023 |
09/02/2023 | Interim | GBP | 1.628 | 23/02/2023 | 24/02/2023 | 27/03/2023 |
10/02/2022 | Interim | GBP | 0.764 | 11/08/2022 | 12/08/2022 | 12/09/2022 |
10/02/2022 | Interim | GBP | 1.453 | 24/02/2022 | 25/02/2022 | 28/03/2022 |
11/02/2021 | Interim | GBP | 0.648 | 12/08/2021 | 13/08/2021 | 13/09/2021 |
05/11/2020 | Interim | GBP | 1.374 | 25/02/2021 | 26/02/2021 | 29/03/2021 |
24/10/2019 | Interim | GBP | 0.696 | 13/08/2020 | 14/08/2020 | 14/09/2020 |
24/10/2019 | Interim | GBP | 1.464 | 27/02/2020 | 28/02/2020 | 30/03/2020 |
08/11/2018 | Interim | USD | 0.9 | 08/08/2019 | 09/08/2019 | 09/09/2019 |
08/11/2018 | Interim | USD | 1.9 | 28/02/2019 | 01/03/2019 | 27/03/2019 |
Top Posts |
---|
Posted at 27/11/2023 23:09 by 1knocker I have placed a limit order to buy at 95. I may pull it in favour of something paying a better dividend. there is plenty to chose from at present. The important thing in this market is not to chase. Let the price come to us. |
Posted at 15/11/2023 10:27 by blackhorse23 Money moving to APH , excellent healthcare dividend company |
Posted at 23/10/2023 15:36 by philanderer AZN stinking the portfolio out today :-S |
Posted at 23/10/2023 15:29 by chc15 Didn't think AZN would be a falling knife, ADR down, this follows, buying again soon. |
Posted at 18/10/2023 11:47 by paa65 Interestingly, if you look at the AZN ADR (in the US) price action from yesterday, at 17:50 UK time it fell 8%Couldn't find any reason why, and it recovered most of it before the close.I assumed a fat finger trade (meant to tell the algos to sell a million but put an extra zero or two on the end).But with it now down over 4% today, may be it wasn't a fat finger after all. |
Posted at 13/9/2023 22:23 by blackhorse23 Switched to APH today , best value healthcare company , dividend yields 6% |
Posted at 09/8/2023 13:16 by philanderer xd tomorrow morning for the 71.8p dividend |
Posted at 11/7/2023 19:30 by gregb AZN debt / bonds have a fixed rate at the outset. |
Posted at 05/7/2023 09:06 by philanderer Berenberg lowers AstraZeneca target priceA lung cancer treatment from AstraZeneca (AZN) failed to meet high investor expectations but the share price drop is ‘overdone̵ Analyst Luisa Hector reiterated her ‘buy’ recommendation but lowered her target price slightly from £135 to £133 on the Citywire Elite Companies AAA-rated stock, which rose 2.2%, or 228p, to £106.02 on Tuesday. The pharmaceutical giant, along with its partner Daiichi Sankyo, announced positive progression-free survival headline data for their lung cancer treatment. ‘The absence of more positive language in the press release, such as “clinically meaningful”, and the occurrence of some fatal interstitial lung disease events missed high investor expectations, resulting in AstraZeneca’s share price falling by 8%,’ said Hector. She said the future of the drug relies on further testing, which is expected in the next six months. ‘We lower our price target to £133… a much smaller reduction than the share price move of 900p. We think the stock reaction is overdone given the overall strength of AstraZeneca’s pipeline,’ she said. citywire.com |
Posted at 11/6/2023 14:30 by diku Compare AZN chart with VOD chart since 2016...complete opposite...AZN in bull run while VOD in bear run.... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |